Group Nierkens

Medicijnen en Levenswetenschappen

1. Cell Transplantation 100%
2. Allogeneic Cells 78%
3. T-Lymphocytes 70%
4. Fetal Blood 47%
5. Metachromatic Leukodystrophy 46%
6. Neuroblastoma 46%
7. Dendritic Cells 43%
8. Immune Reconstitution 33%
9. Pediatrics 33%
10. Immunologic Monitoring 32%
11. fludarabine 31%
12. Immunotherapy 30%
13. Antilymphocyte Serum 29%
14. Cell- and Tissue-Based Therapy 28%
15. Graft vs Host Disease 27%
16. Neoplasms 24%
17. Transplants 23%
18. Organoids 23%
19. Leukemia 21%
20. Transplantation 20%
21. Coronavirus 19%
22. Gene Editing 18%
23. Acute Myeloid Leukemia 18%
24. Precursor Cell Lymphoblastic Leukemia-Lymphoma 17%
25. Vaccines 17%
26. Drug Monitoring 16%
27. Therapeutics 15%
28. Mucopolysaccharidoses 15%
29. Neutrophils 15%
30. Natural Killer Cells 14%
31. Blood Cells 14%
32. Recurrence 14%
33. IFIH1 Interferon-Induced Helicase 13%
34. Mucopolysaccharidosis I 13%
35. Clinical Trials 13%
36. Amyopathic dermatomyositis 12%
37. Clofarabine 12%
38. Monocytes 12%
39. thymoglobulin 12%
40. endothelial PAS domain-containing protein 1 12%
41. Hematologic Neoplasms 12%
42. Survival 12%
43. CD19 Antigens 12%
44. Leukemia, Megakaryoblastic, Acute 12%
45. CRISPR-Associated Protein 9 11%
46. T-Cell Antigen Receptor 11%
47. Chimeric Antigen Receptors 11%
48. Child 11%
49. Biomarkers 11%
50. Semaphorins 11%
51. Hematopoietic Stem Cell Transplantation 10%
52. Mortality 10%
53. anti-IgA 10%
54. Myeloid Cells 10%
55. Systemic Scleroderma 10%
56. Hemophagocytic Lymphohistiocytosis 10%
57. Cell Lineage 9%
58. Mouse Sema3b protein 9%
59. Immunity 9%
60. Datasets 9%
61. Niacinamide 9%
62. Immunoglobulin A 9%
63. B-Lymphoid Precursor Cells 9%
64. Wilms Tumor 9%
65. Pharmacokinetics 9%
66. Strabismus 8%
67. Major Histocompatibility Complex 8%
68. Clustered Regularly Interspaced Short Palindromic Repeats 8%
69. Bone Marrow 8%
70. Antibodies 8%
71. Glial Fibrillary Acidic Protein 8%
72. Intermediate Filaments 8%
73. Tandem Mass Spectrometry 8%
74. Residual Neoplasm 8%
75. Stem Cell Transplantation 8%
76. Liquid Chromatography 8%
77. Databases 7%
78. Proteins 7%
79. Leukocytes 7%
80. Pulmonary Embolism 7%
81. Epigenomics 7%
82. Genes 7%
83. Stem Cells 7%
84. Consensus 7%
85. Systemic Lupus Erythematosus 7%
86. Ligands 7%
87. Decision Making 6%
88. Cytokines 6%
89. Arthritis 6%
90. Synoviocytes 6%
91. Body Surface Area 6%
92. Central Nervous System 6%
93. Disease Progression 6%
94. Rheumatoid Arthritis 6%
95. Fibrosis 6%
96. B-Lymphocytes 6%
97. Young Adult 6%
98. Reactive Oxygen Species 6%
99. White Matter 6%
100. Registries 6%